Salk Cancer Center

Press & News

Salk Institute for Biological Studies - Salk Cancer Center - Press & News

News


Award-winning cancer researcher to join Salk faculty

LA JOLLA—The Salk Institute is excited to welcome Assistant Professor Christina Towers, a top researcher in the field of cancer biology. Towers will join Salk’s renowned NCI-designated Cancer Center to …


Salk Assistant Professor Dannielle Engle awarded over $1 million to study impact of tobacco use on pancreatic cancer

LA JOLLA—Salk Institute Assistant Professor Dannielle Engle has been awarded a New Investigator Award from the Tobacco-Related Disease Research Program (TRDRP) to examine how tobacco use promotes cellular changes that …


Salk Institute and BridgeBio Pharma collaborate to advance therapies for genetically driven disease

LA JOLLA and PALO ALTO, Calif.—The Salk Institute and BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced a three-year collaboration agreement formed to advance cutting-edge academic discoveries in genetically driven diseases …


Salk physician-scientist Edward Stites receives NIH Director’s New Innovator Award

LA JOLLA—Salk Institute Assistant Professor Edward Stites has been named an NIH Director’s New Innovator for 2020 as part of the National Institutes of Health’s High-Risk, High-Reward Research Program. The award “supports …


Imaging method highlights new role for cellular “skeleton” protein

LA JOLLA—While your skeleton helps your body to move, fine skeleton-like filaments within your cells likewise help cellular structures to move. Now, Salk researchers have developed a new imaging method …


The Salk Institute welcomes top scientists in cancer biology and biophysics

LA JOLLA—The Salk Institute is pleased to welcome two new assistant professors in the fields of cancer biology and biophysics, respectively. Daniel Hollern and Pallav Kosuri will bring fresh perspectives …


How cells solve their identity crisis

LA JOLLA—Cancer is often the result of DNA mutations or problems with how cells divide, which can lead to cells “forgetting” what type of cell they are or how to …


Location, location, location: the cell membrane facilitates RAS protein interactions

LA JOLLA—Many cancer medications fail to effectively target the most commonly mutated cancer genes in humans, called RAS. Now, Salk Professor Geoffrey Wahl and a team of scientists have uncovered …


Mysterious tuft cells found to play role in pancreatitis

LA JOLLA—Persistent inflammation of the pancreas (chronic pancreatitis) is a known risk factor for developing pancreatic cancer, the third-deadliest cancer in the United States. Tuft cells—cells sensitive to chemical (chemosensory) …


Salk Institute appoints Leona Flores as executive director of Salk Cancer Center

LA JOLLA—The Salk Institute announced the hiring of Leona Flores, PhD, as executive director of the Salk Cancer Center, to help oversee administrative and scientific management functions as a member …


Mysterious microproteins have major implications for human disease

LA JOLLA—As the tools to study biology improve, researchers are beginning to uncover details into microproteins, small components that appear to be key to some cellular processes, including those involved …


Salk scientist Tony Hunter receives National Cancer Institute Outstanding Investigator Award

LA JOLLA, CA—Salk scientist Tony Hunter has received a National Cancer Institute (NCI) Outstanding Investigator Award (OIA), which supports accomplished leaders in cancer research. Hunter, who is an American Cancer Society …


Mapping normal breast development to better understand cancer

LA JOLLA—Breast cancer is one of the most prevalent cancers, and some forms rank among the most difficult to treat. Its various types and involvement of many different cells makes …


Discovery of how colorectal cancer drug works will help more patients

LA JOLLA—Colorectal cancer is a common lethal disease, and treatment decisions are increasingly influenced by which genes are mutated within each patient. Some patients with a certain gene mutation benefit …


Two therapeutic targets identified for deadly lung cancer

LA JOLLA—The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called LKB1. Salk Institute researchers have now …


More News